Therapeutic Drug Monitoring

11/11/2025

We are planning a Special Issue focusing on the role of AI in TDM and CT. This issue is expected to be developed next year and to be published in February 2027.
We would like to invite you to participate. Both review articles and original articles can be included. Please let us know if you or your team have innovative work that would fit well with the project, and if you would like to submit it to the journal. We also welcome proposals for review articles that you would like to write yourself or review articles by potential authors that you would like to propose to us. Work related both to TDM and CT is of interest.
As usual, the deadline for submissions is the end of June.
Please DM your responses and ideas

09/30/2025

I gained 1,167 followers in the past 90 days! Thank you all for your continued support. I could not have done it without you. 🙏🤗🎉

11/27/2023

As this year is coming to its end, we would like to update you about the progress of our “Special Issue” initiatives.
First, we are confident that the Special Issue “TDM in neuropsychopharmacology: rediscovering old and emerging aspects“with Dr. Schoretsanitis as a Guest Editor that we worked on this year is now finished and will appear in February 2024 as originally scheduled.
As communicated during the annual Editorial Board Meeting in September this year, for the next year we plan a Special Issue on TDM of Immunosuppressive drugs and this is our official invitation to consider your participation in this project and submit innovative work from your research group to be included. Both review articles and original articles are of interest. Proposals for review articles can include submissions you would like to write yourself or proposals of authors whom we should invite to write review articles on specific topics.
We are looking forward to a successful collaboration on our new project and will be glad to read your response and proposals sent to [email protected].
Finally, we would like not to miss this opportunity to remind you that our Special Series “TDM in the Oncology” is an ongoing project and contributions are most welcome!

09/21/2022

Another successful board meeting!

01/24/2022

The Editors of Therapeutic Drug Monitoring are announcing the development of a Special Issue of the Journal dedicated to the pioneering work of Professor Charles Pippenger, the founder of our Journal, who passed away last year. The theme of said Issue will be “Innovations in Therapeutic Drug Monitoring”. Appreciated are original manuscripts, opinion papers as well as critical reviews on emerging technologies and approaches in the field of Therapeutic Drug Monitoring. All of you are invited to submit your high-quality work by June 30.

To allow the proper allocation of your submission, please mention the Special Issue “Innovations in Therapeutic Drug Monitoring” in your cover letter of the submission.

We are looking forward to receiving many exciting manuscripts!

Uwe Christians Maria Shipkova

Editor in Chief Reviews Editor

09/21/2021

09/20/2021

Editorial Board meeting starts off with a beautiful rooftop dinner

07/01/2021

Most recent Impact Factor Report updates:
😃
• The impact factor has greatly improved from 2.073 to 3.681.
• The US has become the #1 contributor by country while Erasmus University remains the #1 contributor by organizations.
• We’re now ranked as the 9th journal in Medical Laboratory Technology with improvement in other categories as well.

05/05/2021

04/20/2021

Most recent PAP articles

Therapeutic Drug Monitoring is a peer-reviewed, multidisciplinary journal directed to an audience of pharmacologists, clinical chemists, laboratorians, pharmacists, drug researchers and toxicologists. It fosters the exchange of knowledge among the various disciplines–clinical pharmacology, patholo...

04/03/2021

IATDMCT 2021 will be held 19-22 September 2021 in Rome, Italy. The proposed theme for the IATDMCT 2021 follows coherently with the themes of the last Congresses, ie. pharmacokinetics, pharmacogenomics, toxicology, the analysis of drugs in biological fluids and new analytical applications, the safety of patients and so on.

SAFE MEETING The IATDMCT 2021 Congress is being organized on-site following all the security procedures in the prospect that the pandemic situation will be controlled by the end of 2021. The Organizing Secretariat is working on a detailed safety protocol to follow and all staff members will be train...